TWIST1 Gene Expression as a Biomarker for Predicting Primary Doxorubicin Resistance in Breast Cancer

Doxorubicin is one of the most commonly used chemotherapeutic agents for adjuvant chemotherapy of breast cancer. In the studies focused on finding biomarkers to predict the response of the patients and tumors to the drugs used, the Twist transcription factor has been suggested as a candidate biomark...

Descripción completa

Detalles Bibliográficos
Autores principales: Demir, S, Müslümanoğlu, MH, Müslümanoğlu, M, Başaran, S, Çalay, ZZ, Aydıner, A, Vogt, U, Çakır, T, Kadıoğlu, H, Artan, S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sciendo 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6956638/
https://www.ncbi.nlm.nih.gov/pubmed/31942413
http://dx.doi.org/10.2478/bjmg-2019-0025

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6956638/
https://www.ncbi.nlm.nih.gov/pubmed/31942413
http://dx.doi.org/10.2478/bjmg-2019-0025

Ejemplares similares